University of California San Francisco (UCSF)

Diving into Research of Biomedical Engineering in Scuba Diving (2017) Cibis T, McEwan A, Sieber A, Eskofier B, Lippmann J, Friedl K, Bennett M Journal article, Review article Varus thrust during walking and the risk of incident and worsening medial tibiofemoral MRI lesions: the Multicenter Osteoarthritis Study (2017) Wink AE, Gross KD, Brown CA, Guermazi A, Roemer F, Niu J, Torner J, et al. Journal article A degradation fragment of type X collagen is a real-time marker for bone growth velocity (2017) Coghlan RF, Oberdorf JA, Sienko S, Aiona MD, Boston BA, Connelly KJ, Bahney C, et al. Journal article Beta-6-Integrin serves as a novel tumor marker and therapeutic target for colorectal carcinoma (2017) Bengs S, Becker E, Spalinger MR, Raselli T, Kasper S, Lang S, Atrott K, et al. Conference contribution Quality assurance guidelines for superficial hyperthermia clinical trials: I. Clinical requirements (2017) Trefna HD, Crezee H, Schmidt M, Marder D, Lamprecht U, Ehmann M, Hartmann J, et al. Journal article Romosozumab (sclerostin monoclonal antibody) versus teriparatide in postmenopausal women with osteoporosis transitioning from oral bisphosphonate therapy: a randomised, open-label, phase 3 trial (2017) Langdahl BL, Libanati C, Crittenden DB, Bolognese MA, Brown JP, Daizadeh NS, Dokoupilova E, et al. Journal article ARHGEF9 disease: Phenotype clarification and genotype-phenotype correlation (2017) Alber M, Kalscheuer VM, Marco E, Sherr E, Lesca G, Till M, Gradek G, et al. Journal article Recommendations for reporting tumor budding in colorectal cancer based on the International Tumor Budding Consensus Conference (ITBCC) 2016 (2017) Lugli A, Kirsch R, Ajioka Y, Bosman F, Cathomas G, Dawson H, El Zimaity H, et al. Journal article Effects of Romosozumab Compared With Teriparatide on Bone Density and Mass at the Spine and Hip in Postmenopausal Women With Low Bone Mass (2017) Genant HK, Engelke K, Bolognese MA, Mautalen C, Brown JP, Recknor C, Goemaere S, et al. Journal article Greater Gains in Spine and Hip Strength for Romosozumab Compared With Teriparatide in Postmenopausal Women With Low Bone Mass (2017) Keaveny TM, Crittenden DB, Bolognese MA, Genant HK, Engelke K, Oliveri B, Brown JP, et al. Journal article